1332 — Touyun Biotech Cashflow Statement
0.000.00%
- HK$505.07m
- HK$875.87m
- HK$198.64m
Annual cashflow statement for Touyun Biotech, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -195 | -172 | -123 | -199 | -273 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 170 | 127 | 104 | 179 | 212 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -211 | 0.804 | -57.2 | -39.6 | 27.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -205 | -15.3 | -53.8 | -26.4 | 3.65 |
Capital Expenditures | -7.64 | -126 | -251 | -12.9 | -17.1 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 163 | 77.6 | 103 | -4.32 | -53.8 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 156 | -47.9 | -148 | -17.2 | -70.9 |
Financing Cash Flow Items | 1.5 | 232 | 29 | 20.9 | 12.5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -7.26 | 160 | 123 | 103 | -27.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -57.1 | 102 | -82.2 | 67.9 | -93.6 |